Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lounis

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|November 17, 2004
In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infectionsN Lounis, G Roscigno
Antimicrobial Agents and Chemotherapy|March 1, 1997
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?N Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1994
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelB Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige miceN Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?B Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapyB Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisB JI, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse modelN Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Clarithromycin is inactive against Mycobacterium tuberculosisC Truffot-Pernot, N Lounis, J H Grosset, et al.
Medecine Et Maladies Infectieuses|May 24, 2016
In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosisN Lounis, L Vranckx, T Gevers, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|November 17, 2004
In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infectionsN Lounis, G Roscigno
Antimicrobial Agents and Chemotherapy|March 1, 1997
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?N Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1994
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelB Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige miceN Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?B Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapyB Ji, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisB JI, N Lounis, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse modelN Lounis, B Ji, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Clarithromycin is inactive against Mycobacterium tuberculosisC Truffot-Pernot, N Lounis, J H Grosset, et al.
Medecine Et Maladies Infectieuses|May 24, 2016
In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosisN Lounis, L Vranckx, T Gevers, et al.
Pageof 3